display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
breast cancer - HER2-positivebreast cancer - HR positivebreast cancer - triple negative
es-BC - HER2 positive - (neo)adjuvant (NA)la/mBC - HR positivela/mBC - HR positive - L2 - all populationmBC - Triple negative (TNBC) - (neo)adjuvant (NA)mBC - Triple negative (TNBC) - 1st Line (L1)la/mBC - TNBC - L2 - all populationla/mBC - TNBC - L2 - PDL1 positivees-BC - Triple negatif (TNBC) - (neo)adjuvant (NA)es-BC - TNBC - NA - all population
chemotherapy
non platinum-based chemotherapy
microtubul inhibitor
eribulin NCT03051659
nucleoside analogues (pyrimidine/purine)
gemcitabine IMpassion-132 ... IMpassion-132 ... IMpassion-132 ... IMpassion-132 ...
taxanes
docetaxel BCTOP-T-A01 arm A/B
paclitaxel
nab-paclitaxel FUTURE-SUPER_immunomodulatory subtype GeparNuevo
paclitaxel followed by doxorubicin plus cyclophosphamide IMpassion-050 IMpassion-050 IMpassion-050
pegylated liposomal doxorubicin and cyclophosphamide ICON NSABP B-59/GBG 96-GeparDouze NSABP B-59/GBG 96-GeparDouze Alice IMpassion-031 ... ALEXANDRA/IMpassion-030 IMpassion-031 ...
platinum-based chemotherapy
platinum derivate
carboplatin NSABP B-59/GBG 96-GeparDouze NSABP B-59/GBG 96-GeparDouze IMpassion-132 ... IMpassion-132 ... TBCRC IMpassion-132 ... IMpassion-132 ...
platinum association
gemcitabine plus platin BCTOP-T-A01 arm A/B

Study type:

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons